Skip to content
Disclosery

GLENMEDE TRUST CO NA: CYTK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GLENMEDE TRUST CO NA on CYTK, newest first. How the timeline and the estimate are built.

GLENMEDE TRUST CO NA held 7,191 CYTK shares at 2026-06-30 per its 13F-HR filed 2026-08-10.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,191 shares
    Change vs previous 13F +528 shares

    <0.01% of the 13F portfolio, value $612,601.

    13F-HR 0001398344-26-013895 filed by GLENMEDE TRUST CO NA
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 6,663 shares
    Change vs previous 13F -6,107 shares

    <0.01% of the 13F portfolio, value $439,158.

    13F-HR 0001398344-26-009724 filed by GLENMEDE TRUST CO NA
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 12,770 shares
    Change vs previous 13F +12,770 shares

    <0.01% of the 13F portfolio, value $811,405.

    13F-HR 0001398344-26-003230 filed by GLENMEDE TRUST CO NA
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -6,261 shares

    13F-HR 0001398344-25-002875 filed by GLENMEDE TRUST CO NA
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2024-09-30
    13F 6,261 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $330,580.

    13F-HR 0001398344-24-020665 filed by GLENMEDE TRUST CO NA
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).